{
  "ticker": "LLY",
  "target_date": "2025-05-28",
  "actual_date": "2025-05-28",
  "collected_at": "2025-12-08T11:49:15.057972",
  "price": {
    "open": 722.57,
    "high": 727.32,
    "low": 712.13,
    "close": 716.7608032226562,
    "volume": 2948800,
    "change_1d_pct": -0.8,
    "change_7d_pct": -5.02,
    "change_30d_pct": -4.44
  },
  "technicals": {
    "rsi_14": 36.55,
    "sma_20": 755.5,
    "sma_50": 784.03,
    "macd": -23.206,
    "macd_signal": -20.497,
    "macd_histogram": -2.709,
    "bb_upper": 846.99,
    "bb_lower": 664.0,
    "price_vs_sma20_pct": -5.13,
    "price_vs_sma50_pct": -8.58,
    "volume_ratio": 0.57
  },
  "fundamentals": {
    "market_cap": 891844493312,
    "pe_ratio": 48.743507,
    "forward_pe": 43.903576,
    "price_to_book": 37.45689,
    "price_to_sales": 15.009214,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.53,
    "pct_from_52w_low": 59.49
  },
  "macro": {
    "spy": {
      "price": 584.38,
      "change_1d_pct": -0.58,
      "change_7d_pct": -1.2
    },
    "vix": {
      "level": 19.31,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.48
    },
    "dollar_index": {
      "level": 99.88
    },
    "gold": {
      "price": 3293.6
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "How Ozempic\u2019s Maker Lost Its Grip on the Obesity Market It Created",
      "source": "DowJones",
      "datetime": 1748466000,
      "summary": "How Ozempic\u2019s Maker Lost Its Grip on the Obesity Market It Created",
      "url": "https://finnhub.io/api/news?id=67b35a900999d1c098ae1d597d7173c0a7ecb8b6a929a291229c163297fb6aa6"
    },
    {
      "headline": "Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer",
      "source": "Yahoo",
      "datetime": 1748446020,
      "summary": "LLY inks $1B deal to acquire SiteOne, adding phase II-ready pain drug STC-004 to strengthen its neuroscience pipeline.",
      "url": "https://finnhub.io/api/news?id=eda5db9e5fa0556ae3e353ed40ba2771cf60688b886c80d1b33c7edbc486d1d8"
    },
    {
      "headline": "New Eli Lilly acquisition to progress potential next-generation pain treatment",
      "source": "Finnhub",
      "datetime": 1748442666,
      "summary": "Eli Lilly and Company has agreed to acquire the biotech SiteOne Therapeutics, Inc. Shareholders of SiteOne will be eligible for a total of $1.0 billion in cash. The deal includes the ...",
      "url": "https://finnhub.io/api/news?id=f9ed1712098098f192668cb79a543961ea2912197d49838686173103b1c91c23"
    },
    {
      "headline": "Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?",
      "source": "Yahoo",
      "datetime": 1748438520,
      "summary": "Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.",
      "url": "https://finnhub.io/api/news?id=e99d9ef03056cbdd5328ef9e962005b9f0fbe23106571652a8668e960b93fb03"
    },
    {
      "headline": "Jim Cramer Notes Eli Lilly (LLY) Stock is at a \u201cDecent Level to Start a Position\u201d",
      "source": "Yahoo",
      "datetime": 1748382870,
      "summary": "We recently published a list of Jim Cramer Had These 21 Stocks on His Radar. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. A caller asked what Cramer\u2019s thoughts on Eli Lilly and Company (NYSE:LLY) were, a",
      "url": "https://finnhub.io/api/news?id=88e5d0865b581f1762271f77f6666d9416d39dfb2a8d56e24b2453f97f995d2c"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-27",
      "description": "xslF345X05/wk-form4_1748376794.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000156/xslF345X05/wk-form4_1748376794.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772733.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/xslF345X05/wk-form4_1747772733.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772668.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000152/xslF345X05/wk-form4_1747772668.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772589.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000150/xslF345X05/wk-form4_1747772589.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772518.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000148/xslF345X05/wk-form4_1747772518.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}